4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001802615-26-000002
Chief Medical Officer gave up 12,679 shares (to pay taxes)
- Chief Medical Officer acquired 37,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arbet-Engels Christophe Chief Medical Officer | 2026-10-01 | Option exercise | +37,500 | 37,500 | D: show line 1 in the form | ||
| Arbet-Engels Christophe Chief Medical Officer | 2026-10-01 | Shares withheld for taxes | −12,679 | $2.76 | $34,994 | 24,821 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arbet-Engels Christophe Chief Medical Officer | 2026-10-01 | Option exercise · Restricted Stock Units | −37,500 | 112,500 | D: show line 3 in the form |
Loading xslF345X06/form4-10052026_041009.xml…